Quebec says it will start using human papillomavirus tests as its primary screening tool for cervical cancer, replacing the Pap smear. The Health Department says the province will systematically offer HPV testing for cervical cancer screening to all women aged 25 to 65, every five years. Earlier this year, the Institut national d’excellence en santé et en services sociaux reported that the HPV test is more sensitive than a Pap smear and could allow patients to collect their own test samples.
Category:
Published on: 1 Jun 2022
McGill researchers identify new markers for early detection of cervical cancer
By Ashley Rabinovitch
Published on: 13 Feb 2020
Researchers seek to answer longstanding debate
Published on: 11 Feb 2019
- Regular cytology screening (pap or smear test) is still the most commonly used HPV screening method, and can prevent cancers up to age 75 years, although benefits decline with age
- For the newly introduced HPV DNA test, which offers a higher degree of accuracy, women aged 55 who have a negative test were predicted to be at low risk of cervical cancer
Published on: 2 Nov 2018
C.A.T.C.H hopes to increase access to vaccinations among vulnerable populations
One of three inaugural projects supported by CHASM, the health-related incubator launched last year by a group of McGill medical students, the Community Ambassadors to Conquer HPV, or C.A.T.C.H hope to contribute, as their name implies, to conquering HPV.
Category:
Published on: 11 Apr 2018
Category:
Published on: 17 Jul 2015
Sexual behaviour of teenage girls does not appear to have been affected by routine human papilloma virus (HPV) vaccination, according to a large study published in CMAJ (Canadian Medical Association Journal).
Category:
Published on: 8 Dec 2014
Oral human papillomavirus (HPV) infections were more common among men who had female partners with oral and/or genital HPV infection, suggesting that the transmission of HPV occurs via oral-oral and oral-genital routes, according to a McGill University study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Category:
Published on: 12 Nov 2014
A new study by McGill University will examine whether vaccinating only one partner in a couple against the human papillomavirus (HPV) can help prevent transmission of HPV to the unvaccinated partner.
Category:
Published on: 30 Jan 2014
The McGill Division of Cancer Epidemiology has recently launched the CATCH study to test the effectiveness of a Carrageenan-based gel in preventing the tranmission of HPV. Carrageenan is derived from red algae, and commonly used as a thickening agent in food products. It could represent an inexpensive method of prevention against the virus, whereas the vaccine and screening procedures are considerably more expensive.
Category:
Published on: 25 Mar 2013
A new study by McGill University’s Division of Cancer Epidemiology will test a revolutionary way of preventing the transmission of the human papillomavirus (HPV) through the use of a topical gel applied during sexual activity.
Category:
Published on: 8 Jan 2013
